Article
Molecular Subgrouping of Medulloblastoma: Impact Upon Research and Clinical Practice
7 Jul 2015
Abstract excerpt
Medulloblastoma, the most common primary pediatric malignant brain tumor is a molecularly heterogeneous disease with different developmental origins, distinct phenotypes, diverse biological behaviour, and contrasting clinical outcomes. The current clinico-radiological risk-classification fails to take account of this heterogeneity and existent prognostic variability. It is widely accepted that dysregulation of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
